Intended Use

The Aulisa Infant Oximeter Module (2nd Gen.) is indicated for spot-checking and/or continuous monitoring SpO2 and pulse rate of infant patients during non-motion and under well-perfused conditions in hospitals, medical facilities, home care, and subacute environments. The parameters derived by the device are transmitted to a commercially available mobile device that runs an Aulisa-developed application for display and review.

Technology

The device is a wireless, foot-worn sensor module that uses non-invasive red and infrared technology to measure SpO2 and pulse rate. Data is transmitted via Bluetooth to third-party mobile devices running an Aulisa-developed app. It includes an oximeter box and a reusable transmissive sensor, with audible and visual alarms generated through the app when abnormal data or technical errors are detected.

Performance

The device successfully passed electrical safety, environmental stress, electromagnetic immunity, performance, mechanical durability, biocompatibility, software validation, security testing, wireless coexistence, clinical testing, usability, bench performance, durability, and battery life testing. Clinical testing validated SpO2 measurement accuracy on healthy subjects with different skin tones according to ISO 80601-2-61 requirements with ARMS less than 3 digits over 70-100% saturation range, confirming safety and effectiveness.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    12/15/2023

    1 year, 1 months
  • 2

    FDA Approval

    1/30/2025

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.